Lymphopenia Tied to Risk of Infection After Radiotherapy
Measuring lymphocytes during or after radiotherapy could provide useful information about infection risk, according to researchers.
Diagnosis & Disease Information
Sarcopenia and Inflammation Linked to Worse Survival in mRCC
Patients who had sarcopenia and an elevated neutrophil-to-lymphocyte ratio had the worst overall survival.
High Baseline Troponin T May Predict MACE After Treatment in Renal Cell Carcinoma
Patients who had high baseline troponin T levels had a more than 3-fold greater risk of MACE.
Olaparib Improves HRQOL in Prostate Cancer
Researchers assessed pain and HRQOL measures with olaparib vs physician’s choice of treatment in patients with prostate cancer.
Trimodal Therapy Appears Equivalent to Radical Cystectomy for Select MIBC Patients
The 5-year metastasis-free survival was similar with trimodal therapy and radical cystectomy.
Molecular Features of Primary and Metastatic Sites Differ in Renal Cell Carcinoma
New findings could inform personalized therapeutic strategies for patients with renal cell carcinoma, according to investigators.
Niraparib Maintenance Failed to Improve Outcomes in Advanced Urothelial Carcinoma
The median progression-free survival was similar between the treatment arms.
Neoadjuvant Chemotherapy Deemed New Standard Care in Urothelial Carcinoma
The study’s primary endpoint was met, and neoadjuvant chemotherapy was considered well tolerated.
AAP Does Not Increase Bone Loss in Metastatic Castration-Sensitive Prostate Cancer
Bone loss was observed in both treatment arms, but abiraterone plus prednisone did not increase bone loss.
AI Tool More Accurately Predicts Long-Term Outcomes in Prostate Cancer
An AI tool outperformed NCCN guidelines for predicting biochemical failure, distant metastasis, prostate cancer-specific survival, and overall survival.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...